Efficacy and safety of switching from branded to generic antiretrovirals in virologically suppressed HIV-infected patients-Reference-Cited by-同舟云学术

Efficacy and safety of switching from branded to generic antiretrovirals in virologically suppressed HIV-infected patients

Published:2017-08-01 Issue:8 Volume:12 Page:e0182007
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Gianotti Nicola^ORCID,Poli Andrea,Galli Laura,Franzin Michela,Tadini Patrizia,Galizzi Nadia,Carbone Alessia,Merli Marco,Muccini Camilla,Oltolini Chiara,Andolina Andrea,Spagnuolo Vincenzo,Lazzarin Adriano,Castagna Antonella

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference26 articles.

1. The changing natural history of HIV disease: before and after the introduction of generic antiretroviral therapy in southern India;N Kumarasamy;Clin Infect Dis,2005

2. UNAIDS. AIDS BY THE NUMBERS 2016. http://www.unaids.org/en/resources/documents/2016/AIDS-by-the-numbers. Accessed 30 November 2016.

3. Do patents prevent access to drugs for HIV indeveloping countries?;E Goemaere;JAMA,2002

4. Commentary: the past, present and future of affordable antiretroviral therapy in Africa;N Ford;Int J Epidemiol,2012

5. Generic and branded drugs for the treatment of people living with HIV/AIDS;JA Bartlett;J Int Assoc Physicians AIDS Care,2007

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. First-line antiretroviral therapy initiation for newly diagnosed people with HIV in the Netherlands: A retrospective analysis from 2016 to 2020;PLOS ONE;2024-07-26

2. Prescriptions of generic antiretroviral drugs in three healthcare centers in the Paris area, France;AIDS;2024-05-30

3. Prevalence of neuropsychiatric adverse events and associated factors among adult patients on dolutegravir attending Mulago ISS clinic;HIV Medicine;2022-11-06

4. Patient-reported outcomes among people living with HIV on single- versus multi-tablet regimens: Data from a real-life setting;PLOS ONE;2022-01-13

5. Effectiveness and tolerability of dolutegravir and abacavir/lamivudine administered as two separate pills compared to their equivalent single‐tablet regimen in a multicentre cohort in Spain;Journal of the International AIDS Society;2021-07